RIDDHI SIDDHI GLUCO BIOLS LTD. (RIDDHI)

BSE: ₹806.90
Stock Performance
Corporate Announcements
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit notice of postal ballot dated 29.05.2026 seeking approval of the members of the Company for passing of resolution(s) as set out in the attached notice.

2026-06-02 19:06:18
Corrigendum To Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St March, 2026

Please find attached corrigendum to consolidated financial results of the Company for the quarter and financial year ended 31.03.2026.

2026-05-25 16:38:58
Corporate Action-Board approves Dividend

The Board of Directors of the Company at their meeting held on Today i.e., 25th MMay, 2026 has recommended the Final Dividend of Rs. 3/- per share (30% of the Face Value) on the Equity shares of the Company for the Financial Year ended 31.03.2026.

2026-05-25 15:03:39
Results - Financial Results For March, 31 2026 (Standalone And Consolidated)

With reference to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submits the Audited Standalone and Consolidated Financial Results of Riddhi Siddhi Gluco Biols Limited for the Quarter and financial Year ended 31.03.2026.

2026-05-25 14:59:19
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Of Riddhi Siddhi Gluco Biols Limited (“Company”) Held On Today I.E. On Monday, 25Th May, 2026.

With reference to above subject and in compliance with the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ("Listing Regulations"), we hereby submit outcome of the meeting of the Board of Directors of Riddhi Siddhi Gluco Biols Limited held on Today i.e., 25th May, 2026.

2026-05-25 14:52:16
Board Meeting Intimation for Approval And Adoption Of Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March, 2026.

Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026.

2026-05-18 19:34:22
Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors Of Riddhi Siddhi Gluco Biols Limited Scheduled To Be Held On 19.05.2026.

The meeting of Board of Directors of Riddhi Siddhi Gluco Biols Limited ("Company") is scheduled to be held on 19/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Financial Year ended 31 March, 2026 and to consider and recommend dividend if any, on the Equity shares of the Company for the Financial year ended 31 March 2026.

2026-05-14 10:53:42
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyRiddhi Siddhi Gluco Biols Ltd- 2CIN NO.L24110GJ1990PLC013967 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 167.07 4Highest Credit Rating during the previous FY BBB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sharad Jain Designation: Company Secretary and Compliance Officer EmailId: sharad@riddhisiddhi.co.in Name of the Chief Financial Officer: Mukeshkumar Samdaria Designation: Chief Financial Officer EmailId: mjain@riddhisiddhi.co.in Date: 30/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

2026-04-30 18:50:49
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit press release for dissemination in public domain.

2026-04-27 17:57:25
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Completion Of Acquisition Of Identified Assets From Cargill India Private Limited.

Pursuant to Regulation 30 of SEBI (LODR) Regulations - 2015- we hereby inform you that Riddhi Siddhi Gluco Biols Limited ("Company") has successfully completed the acquisition of Identified Assets of Cargill India Private Limited ("CIPL") in accordance to Asset Purchase Agreement dated 19.01.2026 entered between Company and CIPL. Kindly update the same on your records.

2026-04-27 17:43:11

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 63.63 18.13 135.52 50.69 14.26 48.90 44.33 28.02 154.61 32.10 40.08 9.05
YOY Revenue Growth % -26.1% -56.86% 373.3% -27.84% -77.58% 169.69% -67.29% -44.72% 984% -34.35% -9.58% -67.7%
Other Income 22.12 22.63 20.20 15.98 20.17 21.23 20.22 26.14 21.17 22.13 14.29 11.00
Total Income 85.75 40.76 155.73 66.67 34.43 70.14 64.55 54.16 175.78 54.24 54.37 20.06
Total Expenses + 68.38 19.88 137.83 58.12 18.42 47.46 49.75 36.16 160.66 37.74 51.88 23.63
Cost of Materials Consumed 6.93 5.15 6.56 6.50 5.52 4.50 5.47 5.66 4.46 3.33 4.55 4.74
Employee Benefit Expense 2.08 2.14 1.96 1.90 2.00 2.15 1.99 2.06 1.94 2.00 1.97 2.08
Other Expenses 7.03 6.85 6.53 10.11 6.80 5.68 6.62 8.40 10.15 6.50 7.94 9.58
Operating Profit -4.75 -1.74 -2.30 -7.43 -4.16 1.44 -5.42 -8.14 -6.05 -5.64 -11.80 -14.58
OPM % -7.5% -9.6% -1.7% -14.7% -29.2% 2.9% -12.2% -29.1% -3.9% -17.6% -29.4% -161.1%
Profit Before Tax + 17.37 20.88 17.90 8.55 16.01 22.68 14.80 18.00 15.13 16.49 2.49 -3.58
Tax Expense 11.21 11.07 11.47 -12.91 -7.88 9.34 68.82 13.37 7.09 2.74 3.78 29.16
Tax % 64.5% 53% 64.1% -151% -49.2% 41.2% 465% 74.3% 46.9% 16.6% 151.6% -
Profit After Tax 6.16 9.81 6.43 21.47 23.89 13.33 -54.02 4.63 8.04 13.75 -1.29 -32.74
EPS (Basic) 8.63 13.76 9.02 30.11 33.50 18.70 -75.76 6.49 11.27 19.30 -1.81 -45.91

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 235.84 135.51 267.98 172.93 521.15 497.65
YOY Revenue Growth % 74.04% -49.43% 54.96% -66.82% 4.72% -
Other Income 68.60 87.77 80.93 67.06 64.05 58.96
Total Income 304.45 223.28 348.90 239.99 585.20 556.62
Total Expenses + 273.91 151.80 284.20 191.56 567.43 574.70
Cost of Materials Consumed 17.08 21.15 25.14 26.42 209.31 179.21
Employee Benefit Expense 8.00 8.20 8.08 7.59 25.53 22.38
Other Expenses 34.16 27.50 30.52 24.12 116.13 96.71
Operating Profit -38.07 -16.29 -16.22 -18.63 -46.27 -77.05
OPM % -16.1% -12% -6.1% -10.8% -8.9% -15.5%
Profit Before Exceptional 30.54 71.48 64.71 48.44 17.77 -18.09
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 30.54 71.48 64.71 48.44 17.77 -18.09
Tax Expense 42.77 83.65 20.84 133.35 15.55 43.72
Tax % 140% 117% 32.2% 275.3% 87.5% -
Profit After Tax -12.23 -12.17 43.87 -84.91 2.22 -61.81
EPS (Basic) -17.16 -17.06 61.53 -119.10 20.09 -65.62

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 1,197.59 1,174.12 1,095.11 965.48 1,298.49 948.84
Property, Plant & Equipment 425.55 432.77 380.46 391.78 736.87 768.62
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.08
Non-Current Investments 605.78 306.54 295.52 208.95 198.17 173.76
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.07 0.09 0.10 0.12 0.13 0.16
Current Assets + 592.73 463.60 454.47 489.95 539.06 991.70
Inventories 43.83 44.51 4.73 4.70 56.15 218.23
Trade Receivables 8.23 12.32 22.79 42.96 50.53 102.13
Cash and Cash Equivalents 108.43 0.09 0.23 10.91 0.12 2.58
Current Investments 0.00 0.00 43.88 0.00 0.00 1.72
LIABILITIES & EQUITY
Total Equity 1,539.02 1,586.63 1,591.70 1,489.73 1,591.51 1,552.16
Equity Share Capital 7.13 7.13 7.13 7.13 7.13 7.13
Other Equity 1,502.09 1,579.50 1,529.65 1,424.87 1,497.31 1,445.66
Non-Current Liabilities 174.49 15.64 14.31 12.83 90.21 96.36
Current Liabilities 145.78 119.15 92.09 95.73 155.83 292.02
Total Liabilities 352.28 197.73 181.99 202.37 246.04 388.38

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities -9.24 -28.30 8.91 0.54 161.27 129.95
Cash from Investing Activities -22.36 20.61 21.05 8.33 -70.53 -91.12
Cash from Financing Activities 139.94 7.55 -40.63 1.93 -93.21 -68.28
Net Increase/Decrease in Cash 108.34 -0.14 -10.68 10.80 -2.47 -29.46